Tags |
|
|
Links |
|
|
Actual - The Basic Use of a Living Trust
Estate planning is a tricky concept, but one you have to tackle. The living trust is a key component of most estate planning efforts.
The
The
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
idea of a Trust began back in the 16th century in England as a way to circumvent the control of the King over property after death. The Kin
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
had the right to distribute a person’s property after his death and people worried that their estates would not be distributed to their he
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
rs by the King. They would deed their property to another entity, usually the Church, in return for the promise that the Church would distr
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
bute it to their heirs according to their wishes. In other words, they were trusting the Church to look out after their interests after the
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ir death.
In the past in the United States, a trust was thought of as being something of use only to the very rich. This perception has ch
In the past in the United States, a trust was thought of as being something of use only to the very rich. This perception has ch
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
nged in the past years and today an instrument known as the Living Trust has become popular. The Living Trust is simply a name given to a t
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ust that is established while you are still living. It is a legal instrument that names three different parties. The person who establishes
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
and funds the trust is called the Grantor, or sometimes the Trustor. The person who controls the assets of the trust is called the Trustee.
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
The third party is the beneficiary, or beneficiaries. They are the people designated to receive the benefits of the trust according to the
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
specific wishes of the Grantor.
To understand the value of a trust in estate planning, you must understand that the title and ownership of
To understand the value of a trust in estate planning, you must understand that the title and ownership of
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
the assets is legally passed to the Living Trust. The Trustee has an obligation to administer the Trust according to the instructions of th
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
Grantor, but from a legal point of view, it is the Trust that is the owner. The Grantor will eventually die, but the Trust does not die. T
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
his is the purpose of the Trust. The legal issues such as estate taxes and probate courts that can hinder and delay the transfer of an inhe
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
itance do not come into play.
Privacy is also insured. The affairs of the Trust do not come under public scrutiny as do the affairs of a p
Privacy is also insured. The affairs of the Trust do not come under public scrutiny as do the affairs of a p
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
obate court. The Trust can also make sure that things are done exactly as the Grantor wanted them done. The family disputes and contested w
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
lls are avoided because the Trust is the owner of the assets and is bound to distribute them according to the terms of the trust. It is not
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
a matter for argument in a court.
Most financial experts suggest that anyone with an Estate of at least $100,000 should be giving some se
Most financial experts suggest that anyone with an Estate of at least $100,000 should be giving some se
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ious consideration to the establishment of a Living Trust. It remains one of the most effective tools in the Estate planning arsenal for gi
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ing a person the peace of mind that comes from knowing that their estate will be handling as they wanted it to be handled after their death
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.actual.org.ua/article/130195/actual-The-Basic-Use-of-a-Living-Trust.html">The Basic Use of a Living Trust</a>
BB link (for phorums):
[url=http://www.actual.org.ua/article/130195/actual-The-Basic-Use-of-a-Living-Trust.html]The Basic Use of a Living Trust[/url]
Related Articles:
8 Non-profit Fundraising Ideas - From a Donor's Perspective PART 1
The Secret to Finding those Niche Markets that Sizzle
Team Development - Easier to Start from Nothing?
Bookmark it:
|